Showing results (1-10 of 699) with videos related to

Sort By:
Pageof 70
Heart Failure Reviews|February 11, 2014
Lipids, statins, and clinical outcomes in heart failure: rethinking the dataMuthiah Vaduganathan, Stephen J Greene, Andrew P Ambrosy, et al.
The Canadian Journal of Cardiology|May 27, 2017
Drug Development for Heart Failure With Preserved Ejection Fraction: What Pieces Are Missing From the Puzzle?Michele Senni, Stephen J Greene, Javed Butler, et al.
Nature Reviews. Cardiology|January 9, 2013
The disconnect between phase II and phase III trials of drugs for heart failureMuthiah Vaduganathan, Stephen J Greene, Andrew P Ambrosy, et al.
The American Journal of Medicine|June 18, 2014
Hemoconcentration-guided diuresis in heart failureMuthiah Vaduganathan, Stephen J Greene, Gregg C Fonarow, et al.
Nature Reviews. Cardiology|February 11, 2015
The vulnerable phase after hospitalization for heart failureStephen J Greene, Gregg C Fonarow, Muthiah Vaduganathan, et al.
Cleveland Clinic Journal of Medicine|June 22, 2006
The clinical effects of vasopressin receptor antagonists in heart failureMihai Gheorghiade
Expert Review of Cardiovascular Therapy|June 25, 2015
Combination decongestion therapy in hospitalized heart failure: loop diuretics, mineralocorticoid receptor antagonists and vasopressin antagonistsMuthiah Vaduganathan, Robert J Mentz, Stephen J Greene, et al.
Circulation. Heart Failure|March 5, 2015
Population risk prediction models for incident heart failure: a systematic reviewJustin B Echouffo-Tcheugui, Stephen J Greene, Lampros Papadimitriou, et al.
ESC Heart Failure|September 5, 2017
Renin-angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta-analysisMuhammad Shahzeb Khan, Gregg C Fonarow, Hassan Khan, et al.
Heart Failure Reviews|October 12, 2012
The immunological axis in heart failure: importance of the leukocyte differentialMuthiah Vaduganathan, Stephen J Greene, Javed Butler, et al.
Pageof 70